INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INJECTION
EXPERT VIEW
Dr Alex Vasiev
THROUGH THICK AND THIN: MODELLING THE DELIVERY OF NON-NEWTONIAN FORMULATIONS
Alex Vasiev explores the challenges inherent in understanding flow rates in injectable drug delivery when dealing with non-Newtonian fluids, and provides an overview of how to calculate flow rates for power law, Carreau and Cross fluids.
INJECTION
Manuela Giacon
Stevanato Group
DELIVERING ON GLP-1 DEMAND: A COMBINATION OF DEVICE OFFERINGS AND SUPPLY STRATEGY
Manuela Giacon and Josh Gordon, review the growth in demand for glucagon-like peptide-1 treatments and present Stevanato Group's response to this exciting opportunity, showcasing its Alina
®
device platform for pen injectors and the Aidaptus
®
two-step, single-use autoinjector.
INJECTION
Cecile Gross
Nemera
ADDRESSING DIABESITY WITH PEN INJECTOR PLATFORMS
Cécile Gross and Mark Tunkel discuss the variety of pen injector platforms to meet the different needs of diabetes patients.
INJECTION
Vetter Pharma
COMPANY SHOWCASE: VETTER PHARMA
Vetter is a CDMO that offers services for pharma and biotech firms of all sizes and locations and holds numerous patents, including technologies for protection against tampering and counterfeiting. Its expertise ranges from lyophilisation (freeze-drying) to siliconisation and more.
EARLY INSIGHT
Dr Nicky Bertollo
Pharma Latch
HOW DO YOU PERCEIVE INTRADERMAL DELIVERY? THINK AGAIN…
Nicky Bertollo, Adam Rock and Ronan Byrne discuss the benefits and limitations of intradermal delivery – and introduce the Pharma Latch Hollow intradermal injection device.
INJECTION
Jeff Clement
PCI Pharma Services
ACCELERATING INNOVATION: THE POWER OF PARALLEL DEVELOPMENT FOR AN AUTOINJECTOR LAUNCH
Jeff Clement and Bill Welch explore the essential considerations for navigating the parallel development of a drug product in a vial and a prefilled syringe for an autoinjector, together with the downstream final assembly and pack considerations, from early-phase clinical trials to commercialisation.
EXPERT VIEW
Dan Cowen
ACCELERATING COMBINATION PRODUCT DEVELOPMENT USING DIGITAL TWIN TECHNOLOGY
Dan Cowen, Sebastian White and Anthony Robinson, discuss the value that implementing a digital twin could provide to drug delivery device design across multiple stages of a development programme.
INJECTION
Dr Michael Adler
ten23 health
TRANSITIONING FROM VIAL TO SUBCUTANEOUS INJECTION DEVICES FOR BIOLOGICAL DRUG PRODUCTS
Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post-launch, especially when transferring from a vial format for intravenous infusion.
INTERVIEW
Reto Jost
Ypsomed
INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES
Reto Jost and Gabriel Kalbermatter talk exclusively with ONdrugDelivery's Guy Furness, discussing the progress Ypsomed has made in advancing its sustainability agenda, particularly the implementation of its ecodesign guideline, the benefits of being an early adopter of sustainability principles, how YpsoMate 5.5 mL has been designed from the ground up with sustainability in mind and where sustainability considerations currently fit into the wider pharma industry.
SUSTAINABILITY
Oli Gould
Owen Mumford
DESIGN FOR SUSTAINABILITY – THE CONSIDERATIONS BROUGHT TO LIFE
Oli Gould explores the use of lifecycle assessment in product design for sustainability to impact the environment positively.
INTERVIEW
Dora Rio
SHL Medical
INTERVIEW with Dora Rio, Head of Sustainability, SHL Medical
Dora Rio discusses various aspects of SHL's approach to sustainability, including how it interacts with other players up and down the value chain, whether reusable or single-use devices are more sustainable and how SHL addresses sustainability concerns beyond CO
2
.
EXPERT VIEW
Su Osorio
SUSTAINABLE BY DESIGN: DEVELOPING PATIENT- AND PLANET-CENTRIC MEDICAL DEVICES
Su Osorio, Stephanie Mou and Charlie Dean, explore the delicate balance between patient and planet centricity and propose a user- and planet-centric approach for the development of sustainable medical devices.
EXPERT VIEW
Catriona Eldridge
PHARMACEUTICAL INDUSTRY SUSTAINABILITY TARGETS, ONE YEAR ON
Catriona Eldridge, analyses whether the pharmaceutical industry is meeting its targets and doing enough in the fight against climate change.
EXPERT VIEW
Alastair Willoughby
REUSABLE VERSUS SINGLE-USE DEVICES: TRADE-OFFS IN IMPROVING SUSTAINABILITY
Alastair Willoughby and Prem-Sagar Tank, explore various device trade-offs for both sustainability and cost in reusable injection devices, and consider how this compares with single-use devices.
SUSTAINABILITY
Alissa Monk
ten23 health
LEVERAGING AI & BIG DATA FOR ECO-DESIGN COLLABORATION IN PHARMA
Alissa Monk, Kami Krista, Cédric Montagnetegy and Carole Schanté, explore the potential of artificial intelligence and big data in eco-design with the aim of transforming the pharmaceutical industry towards greater sustainability.
EXPERT VIEW
Matt Parker
SCALING GLP-1 DRUGS WITHOUT A MOUNTAIN OF WASTE
Matt Parker, Simon Lyons and Alex Lyness, look at how the continued success of glucagon-like peptide-1 drugs is bringing into focus the need for environmentally sustainable self-injection systems. They discuss whether reloadable autoinjectors could be the way to boost sustainability, lower cost per dose, and match the scale and rate of adoption of these new therapies.
OCULAR
Dr Andrea Allmendinger
ten23 health
ADDRESSING INTRAVITREAL PRODUCT MANUFACTURING AND DEVELOPMENT CHALLENGES
Andrea Allmendinger, Hanns-Christian Mahler and Philipp Behrendt discuss the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.
INJECTION
Ian Thompson
Ypsomed
HOW DIABESITY IS SHAPING THE WORLD OF SELF-INJECTION DEVICES
Ian Thompson takes us through the recent history of diabetes and obesity therapeutics, the innovative peptide hormone molecules that have reached the market over the past decades and the equally innovative devices developed to deliver them. He addresses the growing challenge of diabesity, and shows that diabetes and obesity will continue to influence self-injection device development substantially.
EXPERT VIEW
Tom Oakley
Sanner Group
DRUG DELIVERY TRENDS FOR 2024
Tom Oakley and Kamaal de Silva consider how keeping abreast of the latest trends can help the industry predict and prepare for the future and, commenting from Springboard's privileged position at the centre of many of the drug delivery sector’s most exciting developments, discuss the top trends to look out for in 2024.
INJECTION
Peter Schmidt
ZwickRoell
FAST, STANDARD-COMPLIANT AND COST-EFFICIENT TESTING OF PREFILLED SYRINGES FOR OPTIMAL RESULTS
Peter Schmidt presents ZwickRoell’s solutions for testing autoinjectors and wearables to ensure a systematic increase in productivity in the testing lab.
PREFILLED SYRINGES
Hisham Jamal
BBS Automation
NAVIGATING ISO 11608 WITH AUTOMATED EQUIPMENT FOR CUSTOMISED PEN AND AUTOINJECTOR TESTING
Hisham Jamal and Carsten Köhler discuss how teamtechnik’s automated testing machines – built on the foundation of assembly automation legacy – seamlessly align with the ISO 11608 regulations, effectively shaping the future of pen and autoinjector testing.
INTERVIEW
Lilli Zakarija
EdgeOne Medical
Interview with Lilli Zakarija, EdgeOne Medical
Lilli Zakarija talks with Guy Furness about how EdgeOne Medical provides a critical service to companies undertaking drug delivery device development programmes, from small biotech start-ups all the way up to major pharmaceutical players. As part of this discussion, Ms Zakarija delves into the evolution of the drug delivery device industry over the past decades, some common pitfalls companies fall into during device development and what makes this sector such an exciting one to work in.
INJECTION
Antonio Scatena
Gateway Analytical
EXPLORING EXTRACTABLE AND LEACHABLE TESTING STRATEGIES FOR PARENTERALS
Antonio Scatena, Scott Toth and Kyle Chenevert discuss the regulatory landscape regarding extractables and leachables for parenteral drugs and provide guidance on implementing a successful testing approach. Techniques and results interpretation are discussed, emphasising practical advice for developers working towards regulatory submission.
INJECTION
Dr Daniel Primavessy
Midas Pharma
A NOVEL INSTRUMENT TO STREAMLINE COMBINATION PRODUCT DEVELOPMENT
Daniel Primavessy, Sigrid Saaler-Reinhardt, Katarzyna Maksymowicz and Marie Stockton introduce the Gx Inbeneo
®
platform simulator. This tool supports pharmaceutical companies in bridging formulation and medical device development processes, reducing time to market for patient-centric combination products.
Prev
1
…
8
9
10
11
12
…
44
Next
Top
